Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-8.58	113.40	124.04
Graham Fair Price	-3.72	28.61	29.72
PEG	-95.91	-6.87	-3.51
Price/Book	-3.98	2.23	2.32
Price/Cash Flow	-15.52	128.53	152.14
Prices/Earnings	3.45	50.52	48.84
Price/Sales	-7.27	60.50	65.24
Price/FCF	-15.52	128.53	152.14
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-0.63	0.40	0.40
Operating Margin	5.32	0.34	0.32
ROA	-7.46	< 0.005	< 0.005
ROE	0.01	0.01	-7.18
ROIC	< 0.005	< 0.005	10.51
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.07	0.15	-53.90
Dividends QOQ	0.03	0.10	265.87
EBIT QOQ	-0.31	0.09	-70.85
EPS QOQ	-0.14	-0.07	47.19
FCF QOQ	-0.55	0.14	-74.93
Revenue QOQ	-0.01	0.04	168.64
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	< 0.005	0.00	inf
Days Sales Outstanding (DSO)	26.41	0.00	inf
Inventory Turnover	-9537.53	0.00	inf
Debt/Capitalization	0.35	0.37	3.47
Quick Ratio	0.33	0.18	-45.97
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	57.52	57.48	-0.06
Cash	0.57	0.54	-5.71
Capex	-0.29	-0.15	49.15
Free Cash Flow	0.88	1.00	13.60
Revenue	2.04	2.11	3.49
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.55	0.32	-42.38
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	25.11	22.35	-10.97
Naive Interpretation	Member

06 - Financial Health · Bad

Rating